Elias Wagner

17PUBLICATIONS
83CO-AUTHORS
Cellular nervous systemCorrectional theory, offender treatment and rehabilitationPharmacogenomicsSensory systemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 16, 2026
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.

|Mar 02, 2026
Optimising clozapine use through expert consensus: commentary, Wagner & Hasan.

Elias Wagner, Alkomiet Hasan

|Jan 30, 2026
Effectiveness of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics in People With Bipolar Disorder: A Systematic Review and Meta-Analysis of Observational Studies: Efficacité des antipsychotiques injectables à action prolongée par rapport aux antipsychotiques oraux chez les personnes atteintes de troubles bipolaires : revue systématique et méta-analyse d'études observationnelles.

Elias Wagner, Saguna Katyal, In Ok Lee

|Jan 23, 2026
The link between GABA levels and P300 abnormalities in schizophrenia spectrum disorders: regional and symptom-based insights.

Berkhan Karslı, Verena Meisinger, Genc Hasanaj

|Aug 15, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis - ADDENDUM.

Elias Wagner, Nicole Korman, Marco Solmi

|Jun 02, 2025
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis.

Elias Wagner, Nicole Korman, Marco Solmi

Pageof 3

Frequent Collaborators

5 joint publications

Dan Siskind

3 joint publications

Marco Solmi

2 joint publications

Oliver D Howes

2 joint publications

Andrea Schmitt